✦ LIBER ✦

174 A phase II study of capecitabine in patients who have failed first-line treatment for locally advanced or metastatic cervix cancer (MCC)

✍ Scribed by V. Lorvidhaya; P. Phromratanapongs; I. Chitapanarux; P. Kamnerdsupaphon; P. Lertsanguansinchai; C.Y. Hsieh; Y. Kongthanarat; E. Visetsiri

Book ID: 118620349
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 156 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90207-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of capecitabine plus ge

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer

✍ Hong Suk Song; Young Rok Do; Heung Moon Chang; Min Hee Ryu; Kyung Hee Lee; Yeul 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 271 KB

A multicenter phase II study of biweekly

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

✍ Chao, Yee; Hsieh, Jan-Sing; Yeh, Hsien-Tang; Su, Yu-Chieh; Wu, Cheng-Chung; Chen 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 291 KB

263 A study of capecitabine in elderly p

263 A study of capecitabine in elderly patients as first line treatment in advanced or metastatic colorectal cancer

✍ J. Feliu; P. Escudero; F. Losa; M. Bolaños; J. Vicent; A. Yubero; J. Sanz-Lacall 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB

768 - Phase II study of a multi-targeted

768 - Phase II study of a multi-targeted antifolate (LY231514) (MTA) as first line therapy in patients with locally advanced or metastatic colorectal cancer (MCC)

✍ M.C. Cripps; M. Bumell; J. Jolivet; W. Lofters; B. Fisher; L. Panasci; J. Igiesi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Trastuzumab plus docetaxel with or witho

Trastuzumab plus docetaxel with or without capecitabine as first-line therapy for HER2-positive locally advanced or metastatic breast cancer: a randomised Phase II study

✍ A. Wardlev; A. Anton-Torres; X. Pivot; F. Morales-Vasquez; L. Zetina; M. de Fati 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

A phase II open-label randomized study t

A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy

✍ György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 640 KB